|
I STRUCTURE AND FUNCTIONS |
|
|
|
SECTION I STRUCTURE AND DEVELOPMENT |
|
|
|
1 The Vascular Endothelium |
|
|
|
|
|
5 | (3) |
|
|
8 | (3) |
|
2 Development of the Coronary System: Perspectives for Cell Therapy From Precursor Differentiation |
|
|
|
|
|
|
|
|
|
The Evolutionary Origin of Coronary Circulation |
|
|
11 | (1) |
|
Architecture of the Adult Coronary System |
|
|
12 | (1) |
|
Development of the Coronary Vasculature |
|
|
12 | (1) |
|
Coronary Formation From Epicardium-Derived Precursors Proceeding From the Epicardium |
|
|
13 | (2) |
|
The Role of the Epicardium in Coronariogenesis Genesis |
|
|
15 | (1) |
|
Retinoic Acid and VEGF Synchronize the Differentiation of Coronary Smooth Muscle Cells to Endothelial Plexus Formation |
|
|
16 | (1) |
|
New Actors in Coronary Vasculature Formation: Contributions of the Venous Sinus and Endocardium |
|
|
17 | (2) |
|
Development of Coronary Circulation in Zebrafish: A Model to Study Cardiac Regeneration |
|
|
19 | (1) |
|
Exploiting Coronary Developmental Pathways to Regenerate the Injured Heart |
|
|
20 | (1) |
|
|
20 | (2) |
|
|
22 | (1) |
|
3 Signal Transduction Pathways in Endothelial Cells: Implications for Angiogenesis |
|
|
|
|
Maria Theresa O.M. Albuquerque |
|
|
|
|
Kinase Proteins and Phosphatase Proteins |
|
|
23 | (1) |
|
Regulation of Cell Signaling Pathways Depending on Protein Tyrosine Phosphorylation Residues---Tyrosine/PPs |
|
|
23 | (3) |
|
Protein Tyrosine Kinases---Receptor Protein Tyrosine Kinases |
|
|
26 | (1) |
|
Protein Tyrosine Kinases---Cytoplasmic Protein Tyrosine Kinases |
|
|
26 | (2) |
|
Signal Transmission---SH2 and SH3 Domains |
|
|
28 | (1) |
|
Conformational Changes and Posttranslational Modifications (PTM) in Ras |
|
|
29 | (1) |
|
Ras Intracellular Compartmentalization |
|
|
29 | (1) |
|
Ras Signaling Module---ERK1/2 MAP Kinase |
|
|
30 | (1) |
|
Cellular Signaling in the Endothelium: Angiogenesis and Participation of Nitric Oxide (NO) |
|
|
31 | (4) |
|
|
35 | (2) |
|
4 Endothelial Barrier: Factors That Regulate Its Permeability |
|
|
|
|
|
|
37 | (3) |
|
Vascular Permeability Regulation by Opening and Closing Adherens Type Junctions---Principal Mechanisms |
|
|
40 | (4) |
|
Endothelial Barrier Changes Induced by Inflammation in Obesity |
|
|
44 | (1) |
|
Effects of Antioxidants in Increasing Vascular Permeability Induced by I/R |
|
|
45 | (1) |
|
Importance of Plasma Extravasation at the Contact Site With Tissue, Parasite, and Bacteria |
|
|
46 | (1) |
|
|
46 | (1) |
|
|
46 | (2) |
|
|
48 | (1) |
|
5 Vascular Growth Factors, Progenitor Cells, and Angiogenesis |
|
|
|
Luis Henrique Wolff Gowdak |
|
|
|
|
49 | (1) |
|
Vasculogenesis, Angiogenesis, and Atherogenesis |
|
|
50 | (2) |
|
Growth Factors and Angiogenesis Modulation |
|
|
52 | (2) |
|
Vascular Endothelial Growth Factor (VEGF) |
|
|
54 | (2) |
|
Progenitor Cells and Angiogenesis |
|
|
56 | (2) |
|
Therapeutic Application of Stem Cells and Progenitor Cells |
|
|
58 | (2) |
|
|
60 | (1) |
|
|
60 | (2) |
|
|
62 | (1) |
|
6 Characteristics of the Endothelium in Both Sexes |
|
|
|
|
|
|
|
|
Maria Helena Catelli De Carvalho |
|
|
|
63 | (2) |
|
Estrogens, Progesterone, and Testosterone---Mechanisms of Vascular Action |
|
|
65 | (4) |
|
Action of Sex Hormones on Endothelium-Derived Relaxation Factors and Endothelium-Derived Contracting Factors |
|
|
69 | (2) |
|
Endothelium-Derived Hyperpolarizing Factors (EDHFs) |
|
|
71 | (1) |
|
Reactive Oxygen Species (ROS) |
|
|
71 | (2) |
|
Renin-Angiotensin System (RAS) |
|
|
73 | (1) |
|
|
73 | (1) |
|
Estrogen Hormone Treatment---Clinical Studies |
|
|
74 | (1) |
|
New Experimental Approaches |
|
|
75 | (1) |
|
|
76 | (1) |
|
|
76 | (1) |
|
|
77 | (8) |
|
SECTION II ENDOCRINE FUNCTIONS AND METABOLIC INTERACTIONS |
|
|
|
7 Hemodynamic Forces in the Endothelium: From Mechanotransduction to Implications on Development of Atherosclerosis |
|
|
|
|
|
|
|
|
85 | (2) |
|
|
87 | (1) |
|
Physiological Responses of Endothelial Cell Under Shear Stress |
|
|
88 | (4) |
|
Redox Processes in Shear Stress-Induced Signal Transduction in the Endothelium |
|
|
92 | (1) |
|
Mechanical Response to Cyclic Stretch |
|
|
92 | (1) |
|
Hemodynamic Forces and Atherosclerosis Pathophysiology |
|
|
93 | (1) |
|
|
94 | (1) |
|
|
94 | (1) |
|
|
95 | (2) |
|
8 Endothelium-Dependent Vasodilation: Nitric Oxide and Other Mediators |
|
|
|
|
|
|
|
Endothelium-Dependent Vasodilators |
|
|
97 | (1) |
|
|
97 | (10) |
|
|
107 | (4) |
|
|
111 | (1) |
|
|
111 | (1) |
|
|
111 | (2) |
|
|
113 | (2) |
|
9 Vasoconstrictor Substances Produced by the Endothelium |
|
|
|
|
|
|
|
115 | (2) |
|
|
117 | (1) |
|
Endothelium-Derived Contracting Factors |
|
|
117 | (6) |
|
|
123 | (1) |
|
|
124 | (1) |
|
|
125 | (2) |
|
10 Redox Cellular Signaling Pathways in Endothelial Dysfunction and Vascular Disease |
|
|
|
|
|
127 | (2) |
|
Biochemical Characteristics of Redox Processes: Radical and Nonradical Pathways |
|
|
129 | (1) |
|
Antioxidants: The Classical Chemical Concept |
|
|
130 | (1) |
|
Oxidative Stress and Cellular Redox Signaling: Advancing the Concept |
|
|
130 | (1) |
|
|
131 | (1) |
|
A Conceptual Redefinition of Antioxidants |
|
|
132 | (1) |
|
Enzymatic Superoxide Radical Sources in Vessels |
|
|
132 | (5) |
|
Endoplasmic Reticulum and Oxidative Stress |
|
|
137 | (2) |
|
Redox Processes in Vascular Diseases: Vascular Repair to Injury as an Endothelial/Vascular Pathophysiology Model |
|
|
139 | (2) |
|
Atherosclerosis, Endothelial Dysfunction, Redox Pathways, and Lipoprotein Oxidation |
|
|
141 | (1) |
|
NADPH Oxidase in the Pathophysiology of Atherosclerosis |
|
|
142 | (1) |
|
Antioxidants and Atherosclerosis |
|
|
143 | (1) |
|
|
144 | (1) |
|
|
144 | (1) |
|
|
144 | (1) |
|
|
145 | (2) |
|
11 Blood Coagulation and Endothelium |
|
|
|
Joyce M. Annichino-Bizzacchi |
|
|
|
|
147 | (1) |
|
|
147 | (1) |
|
|
147 | (1) |
|
|
148 | (1) |
|
Coagulation Activation Mediated by Endothelial |
|
|
|
|
148 | (1) |
|
Tissue Factor and Tissue Factor Inhibitor |
|
|
149 | (1) |
|
|
149 | (1) |
|
Anticoagulant Properties of the Endothelium |
|
|
149 | (1) |
|
Endothelium and Fibrinolysis |
|
|
150 | (1) |
|
|
151 | (1) |
|
|
151 | (1) |
|
|
152 | (1) |
|
12 Endothelium and Genetics |
|
|
|
|
Gustavo Henrique Oliveira De Paula |
|
|
Jose Eduardo Tanus Dos Santos |
|
|
|
153 | (2) |
|
Thirteen Years After the Conclusion of the Human Genome Project: What Has Changed? |
|
|
155 | (4) |
|
Main Genes Involved in Endothelial Functions |
|
|
159 | (6) |
|
What Does Genomic Medicine Hold for the Future of Endothelial Disease Treatment? |
|
|
165 | (1) |
|
|
166 | (5) |
|
13 Epigenetic Regulation of Endothelial Function: With Focus on MicroRNAs |
|
|
|
|
|
Tiago Fernandesand Edilamar Menezes De Oliveira |
|
|
|
171 | (11) |
|
Potential Role of MicroRNAs in Vascular Therapy |
|
|
182 | (1) |
|
|
183 | (1) |
|
|
184 | (3) |
|
|
187 | (2) |
|
14 Adhesion Molecules and Endothelium |
|
|
|
|
|
|
189 | (1) |
|
|
189 | (1) |
|
Proteins Involved in Leucocyte-Endothelium Interactions |
|
|
190 | (2) |
|
Examples of Adhesion Molecules Participation in Cardiovascular Diseases |
|
|
192 | (7) |
|
|
199 | (2) |
|
|
201 | (2) |
|
15 Endothelium and the Renin-Angiotensin System |
|
|
|
Walkyria Oliveira Sampaio |
|
|
Robson Augusto Souza Dos Santos |
|
|
|
203 | (1) |
|
Expression of RAS Components on Vasculature |
|
|
203 | (3) |
|
SRA on Endothelial Dysfunction, Atherosclerosis, and Thrombosis |
|
|
206 | (3) |
|
|
209 | (8) |
|
II ENDOTHELIAL DYSFUNCTION AND CLINICAL SYNDROMES |
|
|
|
SECTION III METHODS OF INVESTIGATION |
|
|
|
16 Methods to Investigate Endothelial Function in Humans |
|
|
|
|
|
Fernanda Marciano Consolim-Colombo |
|
|
Evaluation of the Endothelial Function in Humans |
|
|
217 | (1) |
|
|
218 | (2) |
|
|
220 | (5) |
|
|
225 | (1) |
|
|
226 | (2) |
|
|
228 | (1) |
|
17 Endothelial Biomarkers |
|
|
|
Francisco Antonio Helfenstein Fonseca |
|
|
|
|
229 | (1) |
|
Endothelial Progenitor Cells and Vascular Repair |
|
|
229 | (2) |
|
MicroRNAs and Endothelial Dysfunction |
|
|
231 | (1) |
|
ICAM, VCAM, and Selectins |
|
|
231 | (1) |
|
|
231 | (1) |
|
|
232 | (5) |
|
SECTION IV AGING AND COGNITIVE FUNCTIONS |
|
|
|
18 Endothelial Alterations in Aging |
|
|
|
|
|
Paulo Magno Martins Dourado |
|
|
Antonio Carlos Palandri Chagas |
|
|
|
237 | (1) |
|
Impairment of Endothelium Dependent Vasodilation Associated With Aging |
|
|
237 | (1) |
|
Structural Changes Related to Cell Replication/Replacement---Telomere Function |
|
|
237 | (4) |
|
Increase in Production of Vasoconstritor Mediators |
|
|
241 | (7) |
|
|
248 | (1) |
|
|
249 | (4) |
|
19 Vascular Function and Cognitive Decline |
|
|
|
|
|
|
|
253 | (1) |
|
|
253 | (1) |
|
Physiopathology of Vascular Dementia |
|
|
253 | (2) |
|
|
255 | (1) |
|
Clinical Presentation of Vascular Dementia |
|
|
255 | (1) |
|
VD and Genetic Alterations |
|
|
256 | (1) |
|
|
257 | (1) |
|
|
258 | (3) |
|
|
261 | (1) |
|
|
261 | (1) |
|
|
262 | (1) |
|
|
263 | (1) |
|
|
263 | (2) |
|
20 Emotional Stress and Influences on Endothelium |
|
|
|
|
|
|
|
265 | (1) |
|
Mental Disorders and Cardiovascular Diseases |
|
|
265 | (2) |
|
Prevalence of Mental Disorders |
|
|
267 | (1) |
|
Costs of Mental Disorders |
|
|
268 | (1) |
|
Endothelium and Cardiovascular Diseases |
|
|
268 | (1) |
|
Stress and Endothelial Dysfunction in General Population |
|
|
269 | (2) |
|
Endothelial Dysfunction and Emotional Stress in Cardiac Diseases |
|
|
271 | (2) |
|
|
273 | (1) |
|
Studies With Animals Subjected to Mental Stress |
|
|
274 | (1) |
|
Mental Stress and Endothelial Dysfunction---Mechanisms |
|
|
274 | (2) |
|
Treatment Options for Mental Diseases and Endothelium Function |
|
|
276 | (3) |
|
|
279 | (3) |
|
|
282 | (3) |
|
|
|
21 Lipids and Lipoprotein Mediators of Endothelial Function and Dysfunction |
|
|
|
Helena Coutinho Franco De Oliveira |
|
|
|
285 | (1) |
|
|
285 | (3) |
|
Lipoproteins of the Postprandial Period |
|
|
288 | (6) |
|
|
294 | (3) |
|
|
|
|
|
|
Antonio Carlos Palandri Chagas |
|
|
|
|
297 | (1) |
|
HDL Structure and Metabolism, Esterification, and Reverse Cholesterol Transport |
|
|
298 | (4) |
|
|
302 | (1) |
|
HDL Atheroprotective Functions |
|
|
303 | (3) |
|
Dysfunctional HDL and Proatherogenic HDL |
|
|
306 | (4) |
|
Treatment With HDL, HDL Mimetics, and CETP Inhibitors |
|
|
310 | (2) |
|
|
312 | (1) |
|
|
313 | (4) |
|
|
317 | (2) |
|
23 Artificial Lipoproteins in Endothelial Dysfunction and Atherosclerosis |
|
|
|
|
|
319 | (1) |
|
|
319 | (4) |
|
|
323 | (2) |
|
Transfer of Lipids to HDL |
|
|
325 | (3) |
|
Use of LDE in Drug Targeting |
|
|
328 | (6) |
|
|
334 | (1) |
|
|
335 | (1) |
|
|
335 | (3) |
|
|
338 | (3) |
|
SECTION VI DIET AND ENDOTHELIUM |
|
|
|
24 Influence of Diet on Endothelial Dysfunction |
|
|
|
|
Maria Silvia Ferrari Lavrador |
|
|
|
Roberta Marcondes Machado |
|
|
|
341 | (2) |
|
|
343 | (1) |
|
Polyunsaturated Fatty Acids |
|
|
343 | (3) |
|
Monounsaturated Fatty Acids |
|
|
346 | (1) |
|
|
347 | (1) |
|
|
348 | (1) |
|
|
349 | (1) |
|
|
350 | (1) |
|
|
350 | (1) |
|
|
351 | (2) |
|
|
353 | (3) |
|
|
356 | (1) |
|
|
356 | (7) |
|
25 Effects of Mediterranean Diet on Endothelial Function |
|
|
|
|
|
|
|
363 | (1) |
|
Scientific Evidence Linking the Mediterranean Diet to Cardiovascular Prevention |
|
|
364 | (2) |
|
Mediterranean Diet and Endothelial Function |
|
|
366 | (12) |
|
Additional Considerations on the Mediterranean Diet and Health |
|
|
378 | (4) |
|
|
382 | (1) |
|
|
383 | (1) |
|
|
383 | (8) |
|
26 Action of Red Wine and Polyphenols Upon Endothelial Function and Clinical Events |
|
|
|
|
|
|
|
391 | (7) |
|
|
398 | (1) |
|
Resveratrol Bioavailability |
|
|
399 | (1) |
|
|
400 | (2) |
|
Wine, Resveratrol, and Cognitive Function |
|
|
402 | (1) |
|
|
402 | (1) |
|
Adverse Effects of Alcohol |
|
|
403 | (1) |
|
Resveratrol and Longevity |
|
|
403 | (1) |
|
Basic Action Mechanisms of Wine and Polyphenols |
|
|
404 | (3) |
|
Endothelial Progenitor Cells |
|
|
407 | (1) |
|
Coagulation and Platelets |
|
|
407 | (1) |
|
|
407 | (1) |
|
|
408 | (1) |
|
|
408 | (2) |
|
|
410 | (1) |
|
|
410 | (8) |
|
|
418 | (3) |
|
SECTION VII KIDNEY AND HYPERTENSION |
|
|
|
27 Kidney and Endothelium |
|
|
|
Jose Jayme Galvao De Lima |
|
|
|
421 | (1) |
|
|
421 | (1) |
|
Nitric Oxide and the Kidney |
|
|
421 | (1) |
|
Endothelium and Nephropathy Progression |
|
|
422 | (1) |
|
Oxidative Stress and Chronic Renal Disease |
|
|
423 | (1) |
|
Other Factors Involved in Nephropathy Progression |
|
|
423 | (1) |
|
Biomarkers of Endothelial Function |
|
|
424 | (1) |
|
Endothelium in Some Types of Renal Disease |
|
|
425 | (1) |
|
|
426 | (1) |
|
|
427 | (1) |
|
|
427 | (2) |
|
28 Endothelium and Arterial Hypertension |
|
|
|
Fernanda Marciano Consolim-Colombo |
|
|
Luiz Aparecido Bortolotto |
|
|
|
429 | (1) |
|
|
429 | (1) |
|
Vasodilators: Nitric Oxide |
|
|
430 | (1) |
|
Immunological Mechanisms and Arterial Hypertension |
|
|
431 | (1) |
|
The Role of Cytokines in Hypertension |
|
|
432 | (1) |
|
Endothelium and Arterial Rigidity in Hypertension |
|
|
433 | (1) |
|
Prognostic Value of Endothelial Dysfunction in Arterial Hypertension |
|
|
434 | (1) |
|
Treatment of Arterial Hypertension and Endothelium |
|
|
434 | (2) |
|
|
436 | (3) |
|
29 Endothelial Alterations in Pulmonary Hypertension |
|
|
|
|
|
|
439 | (1) |
|
Endothelium in Pulmonary Vascular Dysfunction: Decrease in Capacity to Mediate Vasodilation |
|
|
439 | (1) |
|
Participation in Vascular Remodeling Process |
|
|
440 | (2) |
|
Endothelium, Thrombosis and Inflammation in Pulmonary Vascular Disease |
|
|
442 | (1) |
|
Platelets in Pulmonary Vascular Disease |
|
|
443 | (1) |
|
Markers of Microvascular Dysfunction in Pulmonary Vascular Disease |
|
|
444 | (4) |
|
The Future of Biomarkers in Pulmonary Hypertension |
|
|
448 | (1) |
|
|
449 | (6) |
|
SECTION VIII CORONARY DISEASE AND ATHEROSCLEROSIS |
|
|
|
30 Endothelial Alterations in Chronic Coronary Disease |
|
|
|
Aline Alexandra Iannoni De Moraes |
|
|
Antonio Carlos Palandri Chagas |
|
|
|
|
|
455 | (1) |
|
Physiopathological Bases for CAD |
|
|
455 | (8) |
|
Evaluation of Coronary Micorvascular Dysfunction |
|
|
463 | (2) |
|
|
465 | (3) |
|
|
468 | (1) |
|
|
469 | (4) |
|
31 Molecular Mechanisms of the Arterial Wall in Acute Coronary Syndromes |
|
|
|
|
|
Viviane Zorzanelli Rocha Giraldez |
|
|
|
Roberto Rocha C.V. Giraldez |
|
|
|
473 | (1) |
|
Endothelial Dysfunction in Acute Coronary |
|
|
|
|
473 | (5) |
|
Vasospastic and Coronary Microvascular Dysfunction |
|
|
478 | (3) |
|
|
481 | (1) |
|
|
481 | (2) |
|
|
483 | (2) |
|
32 Endothelium: A Coordinator of Acute and Chronic Inflammation |
|
|
|
|
|
Marco Aurelio Lumertz Saffi |
|
|
|
|
485 | (2) |
|
Acute Activation of Endothelial Cells in Septic Shock |
|
|
487 | (1) |
|
The Endothelial Cell in a Chronic Inflammatory State: Atherosclerosis |
|
|
488 | (2) |
|
|
490 | (1) |
|
|
490 | (3) |
|
33 Endothelium in Atherosclerosis: Plaque Formation and Its Complications |
|
|
|
|
Antonio Carlos Palandri Chagas |
|
|
Paulo Magno Martins Dourado |
|
|
|
Introduction and Historical Perspective |
|
|
493 | (1) |
|
|
493 | (1) |
|
Endothelial Dysfunction as Early Event |
|
|
494 | (1) |
|
Cytokines, Adhesion Molecules, and Mononuclear Cells Recruitment |
|
|
494 | (3) |
|
Monocytes and Endothelium |
|
|
497 | (1) |
|
|
498 | (2) |
|
LDL Modifications, Foam Cells Formation, and Pathophysiological Implications |
|
|
500 | (1) |
|
Concept of Inflammation---A Synopsis |
|
|
501 | (2) |
|
|
503 | (1) |
|
Smooth Muscle Cells and Fibrotic Plaque Formation |
|
|
503 | (1) |
|
Participation of the Renin-Angiotensin-Aldosterone System in Atherosclerosis |
|
|
504 | (1) |
|
Oxidative Stress and Atherosclerosis |
|
|
504 | (1) |
|
Interactions Between Endothelial Dysfunction Redox Pathways, Lipoprotein Oxidation, and Atherosclerosis |
|
|
505 | (1) |
|
Plaque Rupture, Erosion, and Thrombosis |
|
|
505 | (4) |
|
|
509 | (3) |
|
|
512 | (1) |
|
34 Endothelial Function and Cardiovascular Risk Factors |
|
|
|
|
|
|
513 | (1) |
|
Normal and Dysfunctional Endothelium Activities |
|
|
513 | (1) |
|
Endothelial Activity Assessment Methods |
|
|
514 | (1) |
|
Endothelial Activity and Prognosis |
|
|
514 | (1) |
|
Risk Factors and Endothelial Function |
|
|
515 | (5) |
|
|
520 | (1) |
|
|
521 | (1) |
|
|
522 | (1) |
|
|
522 | (4) |
|
|
526 | (1) |
|
35 Sleep Disorders and Endothelial Dysfunction |
|
|
|
|
|
|
|
527 | (1) |
|
Endothelial Function in OSA |
|
|
527 | (3) |
|
Effect of Treatment for OSA in the Endothelial Function |
|
|
530 | (3) |
|
|
533 | (1) |
|
|
533 | (4) |
|
36 Smoking and the Endothelium |
|
|
|
|
|
|
|
537 | (2) |
|
|
539 | (7) |
|
Current Stage of Knowledge |
|
|
546 | (3) |
|
Clinical Implications and Practical Applications |
|
|
549 | (2) |
|
|
551 | (3) |
|
|
554 | (1) |
|
37 Endothelial Dysfunction and Coronary Microvascular Dysfunction in Women With Angina and Nonobstructive Coronaries |
|
|
|
|
|
|
|
|
|
555 | (1) |
|
|
556 | (4) |
|
|
560 | (1) |
|
Mechanistic Pathways Leading to Adverse Events |
|
|
560 | (1) |
|
|
561 | (1) |
|
|
561 | (4) |
|
|
|
38 Endothelial Alterations in Heart Failure---Mechanisms and Molecular Basis |
|
|
|
|
|
|
|
|
565 | (1) |
|
|
565 | (1) |
|
|
565 | (2) |
|
Oxidative Stress and eNOS Alterations |
|
|
567 | (3) |
|
Pathophysiologic Implications |
|
|
570 | (1) |
|
Therapeutic Implications Involving Pathophysiological Aspects of Endothelial Dysfunction |
|
|
571 | (1) |
|
The Role of Physical Exercise in Improvement of Endothelial Function in Heart Failure |
|
|
571 | (1) |
|
|
572 | (1) |
|
|
572 | (1) |
|
|
573 | (2) |
|
39 Heart Failure: Influence of Drug Interventions on Vessels |
|
|
|
|
Iascara Wozniak De Campos |
|
|
|
|
575 | (1) |
|
Endothelium and Vasomotor Control |
|
|
576 | (3) |
|
Drug Intervention in Acute Heart Failure |
|
|
579 | (2) |
|
Drug Intervention in Chronic Heart Failure |
|
|
581 | (5) |
|
|
586 | (1) |
|
|
587 | (1) |
|
|
588 | (3) |
|
SECTION X PERCUTANEOUS CORONARY INTERVENTIONS AND CARDIAC SURGERY |
|
|
|
40 Postpercutaneous Interventions: Endothelial Repair |
|
|
|
|
|
|
|
591 | (1) |
|
Neointima and Reestenosis |
|
|
591 | (2) |
|
|
593 | (1) |
|
Angioplasty With Conventional Stent |
|
|
594 | (1) |
|
Angioplasty With Drug-Eluting Stent |
|
|
594 | (1) |
|
Angioplasty With Bioabsorbable Scaffolds |
|
|
595 | (1) |
|
|
595 | (1) |
|
|
595 | (2) |
|
41 Stents and the Endothelium |
|
|
|
|
|
|
|
|
597 | (1) |
|
Poststent Acute Endothelial Response: Cellular and Molecular Mechanisms |
|
|
597 | (2) |
|
|
599 | (2) |
|
|
601 | (2) |
|
Hypersensitivity Reactions |
|
|
603 | (1) |
|
Bioabsorbable Vascular Supports (Bioresorbable Stents) |
|
|
604 | (1) |
|
|
605 | (2) |
|
|
607 | (1) |
|
|
608 | (1) |
|
42 Vascular Disease of the Transplanted Heart: Physiopathology and Therapeutic Options |
|
|
|
|
Noedir Antonio Groppo Stolf |
|
|
|
|
609 | (1) |
|
|
609 | (1) |
|
Vascular Disease of the Graft |
|
|
610 | (11) |
|
|
621 | (2) |
|
|
623 | (6) |
|
SECTION XI DIABETES AND ERECTILE DYSFUNCTION |
|
|
|
43 Erectile Dysfunction and the Endothelium |
|
|
|
|
|
|
629 | (1) |
|
Contractile and Relaxing Substances Derived From Endothelium and Nervous Fibers |
|
|
629 | (3) |
|
Role of Endothelium in Erectile Function and Dysfunction: Focus on the NO-GCS-PDE5 Pathway |
|
|
632 | (2) |
|
Androgens and Erectile Function |
|
|
634 | (1) |
|
Possible Therapeutic Role of Substances That Act Directly in Soluble Guanilato Cyclase for the Treatment of Eretric Dysfunction |
|
|
634 | (1) |
|
|
635 | (1) |
|
|
635 | (2) |
|
|
637 | (2) |
|
44 Obesity, Diabetes, and Endothelium: Molecular Interactions |
|
|
|
|
|
639 | (1) |
|
Mechanisms Responsible for Endothelial Disorder in the Obese |
|
|
639 | (2) |
|
Obesity, Resistance to Insulin and Angiotensin |
|
|
641 | (1) |
|
Molecular Events Related to Interaction of Insulin Versus Angiotensin |
|
|
641 | (5) |
|
Endoplasmic Reticulum Stress and Endothelial Dysfunction |
|
|
646 | (1) |
|
Mechanisms Responsible for Endothelial Dysfunction in Diabetes |
|
|
647 | (1) |
|
Hyperglycemia Induces Increases in ROS Production |
|
|
647 | (2) |
|
Glycolytic Flow Change to Alternative Pathway Induced by Hyperglycemia |
|
|
649 | (1) |
|
Change in Glycolytic Flow to Alternative Pathway Induced by Hyperglycemia |
|
|
649 | (1) |
|
Blocking of PPP Induced by Hyperglycemia |
|
|
650 | (1) |
|
Activation of PKC Induced by Hyperglycemia |
|
|
650 | (1) |
|
|
651 | (1) |
|
|
651 | (4) |
|
SECTION XII NON-CARDIOVASCULAR DISEASES AND ENDOTHELIUM |
|
|
|
45 Endothelial Mechanisms in Preeclampsia |
|
|
|
|
Rossana Pulcineli Vieira Francisco |
|
|
|
|
655 | (2) |
|
Evidence of Endothelial Damage in Preeclampsia |
|
|
657 | (2) |
|
Activation of the Coagulation System |
|
|
659 | (2) |
|
|
661 | (1) |
|
|
661 | (1) |
|
Endothelium Research Methods |
|
|
662 | (1) |
|
Conclusion and Physiopathological Model |
|
|
662 | (2) |
|
|
664 | (1) |
|
|
664 | (3) |
|
46 Endothelium and Nitric Oxide: Interactions in Cancer Evolution |
|
|
|
|
|
Elaine Guadelupe Rodrigues |
|
|
|
The Endothelium and Nitric Oxide |
|
|
667 | (1) |
|
Nitric Oxide as a Connecting Element Between Angiogenesis and Tumor Development |
|
|
668 | (2) |
|
|
670 | (3) |
|
47 Endothelial Function in Skin Microcirculation |
|
|
|
|
|
|
673 | (1) |
|
Anatomy of Skin Microvascularization |
|
|
673 | (1) |
|
|
674 | (3) |
|
Changes in the Endothelial Function Due to Conditions of the Skin Itself |
|
|
677 | (1) |
|
|
678 | (5) |
|
SECTION XIII TREATMENT OF ENDOTHELIAL DYSFUNCTION |
|
|
|
48 Clinical Endothelial Dysfunction: Prognosis and Therapeutic Target |
|
|
|
|
|
|
|
683 | (6) |
|
Endothelium as a Therapeutic Target |
|
|
689 | (4) |
|
|
693 | (4) |
|
|
697 | (2) |
|
49 Physical Exercise and the Endothelium |
|
|
|
|
|
Maria Janieire De Nazare Nunes Alves |
|
|
Allan Robson Kluser Sales |
|
|
|
699 | (1) |
|
Vascular Blood Flow Regulatory Mechanisms During the Exercise |
|
|
699 | (3) |
|
Vascular Blood Flow Regulatory Mechanisms During Exercise in Pathological Conditions |
|
|
702 | (1) |
|
Effects of Physical Training in Endothelial Function |
|
|
703 | (3) |
|
|
706 | (5) |
|
50 Endothelium and Immunological Alterations in Atherosclerosis |
|
|
|
|
The Potential Role of Innate Immunity in Atherogenesis |
|
|
711 | (1) |
|
Neutrophils, Nets, and Atherosclerosis |
|
|
712 | (1) |
|
The Role of Adaptive Immunity in Atherosclerosis |
|
|
712 | (2) |
|
|
714 | (1) |
|
|
714 | (1) |
|
|
714 | (3) |
Index |
|
717 | |